Showing results (1-10 of 979) with videos related to
Sort By:
Pageof 98
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 8, 2016
The ERK cascade inhibitors: Towards overcoming resistanceGalia Maik-Rachline, Rony SegerDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 8, 2016
Role of the tumor stroma in resistance to anti-angiogenic therapyElisabeth J M Huijbers, Judy R van Beijnum, Victor L Thijssen, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 21, 2012
Understanding resistance to combination chemotherapyJustin R Pritchard, Douglas A Lauffenburger, Michael T HemannDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 21, 2012
From tumor prevention to therapy: empowering p53 to fight backChristian Frezza, Carla P MartinsDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 23, 2015
Dysregulation of ubiquitin ligases in cancerJianfei Qi, Ze'ev A RonaiDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 23, 2015
Gemcitabine resistance in pancreatic ductal adenocarcinomaYoav Binenbaum, Shorook Na'ara, Ziv GilDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 3, 2016
Mitotic catastrophe and cancer drug resistance: A link that must to be brokenTatiana V Denisenko, Irina V Sorokina, Vladimir Gogvadze, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 3, 2016
Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equationJosé Alexandre Ferreira, Andreia Peixoto, Manuel Neves, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 18, 2015
Inhibition of proteasome deubiquitinase activity: a strategy to overcome resistance to conventional proteasome inhibitors?Karthik Selvaraju, Magdalena Mazurkiewicz, Xin Wang, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 30, 2015
Fighting cancer drug resistance: Opportunities and challenges for mutation-specific EGFR inhibitorsMichael Juchum, Marcel Günther, Stefan A LauferPageof 98